Pharma & Healthcare
Global 2-valent HPV Vaccine (2vHPV) Market Research Report 2025
- Oct 21, 25
- ID: 369613
- Pages: 81
- Figures: 85
- Views: 18
Report Scope
This report aims to provide a comprehensive presentation of the global market for 2-valent HPV Vaccine (2vHPV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 2-valent HPV Vaccine (2vHPV).
The 2-valent HPV Vaccine (2vHPV) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 2-valent HPV Vaccine (2vHPV) market comprehensively. Regional market sizes, concerning products by Type, by Application, by Immunization Schedule and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 2-valent HPV Vaccine (2vHPV) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Immunization Schedule and by regions.
By Company
GlaxoSmithKline Biologicals
Merck
Beijing Wantai Biological Pharmacy Enterprise
Xiamen Innovax Biotech
Serum Institute of India
Walvax Biotechnology
Segment by Type
HPV16
HPV18
Segment by Immunization Schedule
2-Dose Regimen
3-Dose Regimen
Segment by Application
9-16 Years Old
16-20 Years Old
20-26 Years Old
26-45 Years Old
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 2-valent HPV Vaccine (2vHPV) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of 2-valent HPV Vaccine (2vHPV) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for 2-valent HPV Vaccine (2vHPV), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 2-valent HPV Vaccine (2vHPV).
The 2-valent HPV Vaccine (2vHPV) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 2-valent HPV Vaccine (2vHPV) market comprehensively. Regional market sizes, concerning products by Type, by Application, by Immunization Schedule and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 2-valent HPV Vaccine (2vHPV) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Immunization Schedule and by regions.
By Company
GlaxoSmithKline Biologicals
Merck
Beijing Wantai Biological Pharmacy Enterprise
Xiamen Innovax Biotech
Serum Institute of India
Walvax Biotechnology
Segment by Type
HPV16
HPV18
Segment by Immunization Schedule
2-Dose Regimen
3-Dose Regimen
Segment by Application
9-16 Years Old
16-20 Years Old
20-26 Years Old
26-45 Years Old
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of 2-valent HPV Vaccine (2vHPV) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of 2-valent HPV Vaccine (2vHPV) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 2-valent HPV Vaccine (2vHPV) Market Overview
1.1 Product Definition
1.2 2-valent HPV Vaccine (2vHPV) by Type
1.2.1 Global 2-valent HPV Vaccine (2vHPV) Market Value Comparison by Type (2024 VS 2031)
1.2.2 HPV16
1.2.3 HPV18
1.3 2-valent HPV Vaccine (2vHPV) by Immunization Schedule
1.3.1 Global 2-valent HPV Vaccine (2vHPV) Market Value Comparison by Immunization Schedule: 2024 VS 2031
1.3.2 2-Dose Regimen
1.3.3 3-Dose Regimen
1.4 2-valent HPV Vaccine (2vHPV) by Application
1.4.1 Global 2-valent HPV Vaccine (2vHPV) Market Value by Application (2024 VS 2031)
1.4.2 9-16 Years Old
1.4.3 16-20 Years Old
1.4.4 20-26 Years Old
1.4.5 26-45 Years Old
1.5 Global 2-valent HPV Vaccine (2vHPV) Market Size Estimates and Forecasts
1.5.1 Global 2-valent HPV Vaccine (2vHPV) Revenue 2020-2031
1.5.2 Global 2-valent HPV Vaccine (2vHPV) Sales 2020-2031
1.5.3 Global 2-valent HPV Vaccine (2vHPV) Market Average Price (2020-2031)
1.6 Assumptions and Limitations
2 2-valent HPV Vaccine (2vHPV) Market Competition by Manufacturers
2.1 Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Manufacturers (2020-2025)
2.2 Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global 2-valent HPV Vaccine (2vHPV) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of 2-valent HPV Vaccine (2vHPV), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Product Type & Application
2.7 Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Date of Enter into This Industry
2.8 Global 2-valent HPV Vaccine (2vHPV) Market Competitive Situation and Trends
2.8.1 Global 2-valent HPV Vaccine (2vHPV) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest 2-valent HPV Vaccine (2vHPV) Players Market Share by Revenue
2.8.3 Global 2-valent HPV Vaccine (2vHPV) Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global 2-valent HPV Vaccine (2vHPV) Market Scenario by Region
3.1 Global 2-valent HPV Vaccine (2vHPV) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global 2-valent HPV Vaccine (2vHPV) Sales by Region: 2020-2031
3.2.1 Global 2-valent HPV Vaccine (2vHPV) Sales by Region: 2020-2025
3.2.2 Global 2-valent HPV Vaccine (2vHPV) Sales by Region: 2026-2031
3.3 Global 2-valent HPV Vaccine (2vHPV) Revenue by Region: 2020-2031
3.3.1 Global 2-valent HPV Vaccine (2vHPV) Revenue by Region: 2020-2025
3.3.2 Global 2-valent HPV Vaccine (2vHPV) Revenue by Region: 2026-2031
3.4 North America 2-valent HPV Vaccine (2vHPV) Market Facts & Figures by Country
3.4.1 North America 2-valent HPV Vaccine (2vHPV) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2031)
3.4.3 North America 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe 2-valent HPV Vaccine (2vHPV) Market Facts & Figures by Country
3.5.1 Europe 2-valent HPV Vaccine (2vHPV) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2031)
3.5.3 Europe 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 2-valent HPV Vaccine (2vHPV) Market Facts & Figures by Region
3.6.1 Asia Pacific 2-valent HPV Vaccine (2vHPV) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific 2-valent HPV Vaccine (2vHPV) Sales by Region (2020-2031)
3.6.3 Asia Pacific 2-valent HPV Vaccine (2vHPV) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America 2-valent HPV Vaccine (2vHPV) Market Facts & Figures by Country
3.7.1 Latin America 2-valent HPV Vaccine (2vHPV) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2031)
3.7.3 Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa 2-valent HPV Vaccine (2vHPV) Market Facts & Figures by Country
3.8.1 Middle East and Africa 2-valent HPV Vaccine (2vHPV) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2031)
3.8.3 Middle East and Africa 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 2-valent HPV Vaccine (2vHPV) Sales by Type (2020-2031)
4.1.1 Global 2-valent HPV Vaccine (2vHPV) Sales by Type (2020-2025)
4.1.2 Global 2-valent HPV Vaccine (2vHPV) Sales by Type (2026-2031)
4.1.3 Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Type (2020-2031)
4.2 Global 2-valent HPV Vaccine (2vHPV) Revenue by Type (2020-2031)
4.2.1 Global 2-valent HPV Vaccine (2vHPV) Revenue by Type (2020-2025)
4.2.2 Global 2-valent HPV Vaccine (2vHPV) Revenue by Type (2026-2031)
4.2.3 Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Type (2020-2031)
4.3 Global 2-valent HPV Vaccine (2vHPV) Price by Type (2020-2031)
5 Segment by Application
5.1 Global 2-valent HPV Vaccine (2vHPV) Sales by Application (2020-2031)
5.1.1 Global 2-valent HPV Vaccine (2vHPV) Sales by Application (2020-2025)
5.1.2 Global 2-valent HPV Vaccine (2vHPV) Sales by Application (2026-2031)
5.1.3 Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Application (2020-2031)
5.2 Global 2-valent HPV Vaccine (2vHPV) Revenue by Application (2020-2031)
5.2.1 Global 2-valent HPV Vaccine (2vHPV) Revenue by Application (2020-2025)
5.2.2 Global 2-valent HPV Vaccine (2vHPV) Revenue by Application (2026-2031)
5.2.3 Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Application (2020-2031)
5.3 Global 2-valent HPV Vaccine (2vHPV) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline Biologicals
6.1.1 GlaxoSmithKline Biologicals Company Information
6.1.2 GlaxoSmithKline Biologicals Description and Business Overview
6.1.3 GlaxoSmithKline Biologicals 2-valent HPV Vaccine (2vHPV) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Biologicals 2-valent HPV Vaccine (2vHPV) Product Portfolio
6.1.5 GlaxoSmithKline Biologicals Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck 2-valent HPV Vaccine (2vHPV) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck 2-valent HPV Vaccine (2vHPV) Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Beijing Wantai Biological Pharmacy Enterprise
6.3.1 Beijing Wantai Biological Pharmacy Enterprise Company Information
6.3.2 Beijing Wantai Biological Pharmacy Enterprise Description and Business Overview
6.3.3 Beijing Wantai Biological Pharmacy Enterprise 2-valent HPV Vaccine (2vHPV) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Beijing Wantai Biological Pharmacy Enterprise 2-valent HPV Vaccine (2vHPV) Product Portfolio
6.3.5 Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
6.4 Xiamen Innovax Biotech
6.4.1 Xiamen Innovax Biotech Company Information
6.4.2 Xiamen Innovax Biotech Description and Business Overview
6.4.3 Xiamen Innovax Biotech 2-valent HPV Vaccine (2vHPV) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Xiamen Innovax Biotech 2-valent HPV Vaccine (2vHPV) Product Portfolio
6.4.5 Xiamen Innovax Biotech Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Company Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India 2-valent HPV Vaccine (2vHPV) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Serum Institute of India 2-valent HPV Vaccine (2vHPV) Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Company Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology 2-valent HPV Vaccine (2vHPV) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Walvax Biotechnology 2-valent HPV Vaccine (2vHPV) Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 2-valent HPV Vaccine (2vHPV) Industry Chain Analysis
7.2 2-valent HPV Vaccine (2vHPV) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 2-valent HPV Vaccine (2vHPV) Production Mode & Process Analysis
7.4 2-valent HPV Vaccine (2vHPV) Sales and Marketing
7.4.1 2-valent HPV Vaccine (2vHPV) Sales Channels
7.4.2 2-valent HPV Vaccine (2vHPV) Distributors
7.5 2-valent HPV Vaccine (2vHPV) Customer Analysis
8 2-valent HPV Vaccine (2vHPV) Market Dynamics
8.1 2-valent HPV Vaccine (2vHPV) Industry Trends
8.2 2-valent HPV Vaccine (2vHPV) Market Drivers
8.3 2-valent HPV Vaccine (2vHPV) Market Challenges
8.4 2-valent HPV Vaccine (2vHPV) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 2-valent HPV Vaccine (2vHPV) by Type
1.2.1 Global 2-valent HPV Vaccine (2vHPV) Market Value Comparison by Type (2024 VS 2031)
1.2.2 HPV16
1.2.3 HPV18
1.3 2-valent HPV Vaccine (2vHPV) by Immunization Schedule
1.3.1 Global 2-valent HPV Vaccine (2vHPV) Market Value Comparison by Immunization Schedule: 2024 VS 2031
1.3.2 2-Dose Regimen
1.3.3 3-Dose Regimen
1.4 2-valent HPV Vaccine (2vHPV) by Application
1.4.1 Global 2-valent HPV Vaccine (2vHPV) Market Value by Application (2024 VS 2031)
1.4.2 9-16 Years Old
1.4.3 16-20 Years Old
1.4.4 20-26 Years Old
1.4.5 26-45 Years Old
1.5 Global 2-valent HPV Vaccine (2vHPV) Market Size Estimates and Forecasts
1.5.1 Global 2-valent HPV Vaccine (2vHPV) Revenue 2020-2031
1.5.2 Global 2-valent HPV Vaccine (2vHPV) Sales 2020-2031
1.5.3 Global 2-valent HPV Vaccine (2vHPV) Market Average Price (2020-2031)
1.6 Assumptions and Limitations
2 2-valent HPV Vaccine (2vHPV) Market Competition by Manufacturers
2.1 Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Manufacturers (2020-2025)
2.2 Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global 2-valent HPV Vaccine (2vHPV) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of 2-valent HPV Vaccine (2vHPV), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Product Type & Application
2.7 Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Date of Enter into This Industry
2.8 Global 2-valent HPV Vaccine (2vHPV) Market Competitive Situation and Trends
2.8.1 Global 2-valent HPV Vaccine (2vHPV) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest 2-valent HPV Vaccine (2vHPV) Players Market Share by Revenue
2.8.3 Global 2-valent HPV Vaccine (2vHPV) Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global 2-valent HPV Vaccine (2vHPV) Market Scenario by Region
3.1 Global 2-valent HPV Vaccine (2vHPV) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global 2-valent HPV Vaccine (2vHPV) Sales by Region: 2020-2031
3.2.1 Global 2-valent HPV Vaccine (2vHPV) Sales by Region: 2020-2025
3.2.2 Global 2-valent HPV Vaccine (2vHPV) Sales by Region: 2026-2031
3.3 Global 2-valent HPV Vaccine (2vHPV) Revenue by Region: 2020-2031
3.3.1 Global 2-valent HPV Vaccine (2vHPV) Revenue by Region: 2020-2025
3.3.2 Global 2-valent HPV Vaccine (2vHPV) Revenue by Region: 2026-2031
3.4 North America 2-valent HPV Vaccine (2vHPV) Market Facts & Figures by Country
3.4.1 North America 2-valent HPV Vaccine (2vHPV) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2031)
3.4.3 North America 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe 2-valent HPV Vaccine (2vHPV) Market Facts & Figures by Country
3.5.1 Europe 2-valent HPV Vaccine (2vHPV) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2031)
3.5.3 Europe 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 2-valent HPV Vaccine (2vHPV) Market Facts & Figures by Region
3.6.1 Asia Pacific 2-valent HPV Vaccine (2vHPV) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific 2-valent HPV Vaccine (2vHPV) Sales by Region (2020-2031)
3.6.3 Asia Pacific 2-valent HPV Vaccine (2vHPV) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America 2-valent HPV Vaccine (2vHPV) Market Facts & Figures by Country
3.7.1 Latin America 2-valent HPV Vaccine (2vHPV) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2031)
3.7.3 Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa 2-valent HPV Vaccine (2vHPV) Market Facts & Figures by Country
3.8.1 Middle East and Africa 2-valent HPV Vaccine (2vHPV) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2031)
3.8.3 Middle East and Africa 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 2-valent HPV Vaccine (2vHPV) Sales by Type (2020-2031)
4.1.1 Global 2-valent HPV Vaccine (2vHPV) Sales by Type (2020-2025)
4.1.2 Global 2-valent HPV Vaccine (2vHPV) Sales by Type (2026-2031)
4.1.3 Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Type (2020-2031)
4.2 Global 2-valent HPV Vaccine (2vHPV) Revenue by Type (2020-2031)
4.2.1 Global 2-valent HPV Vaccine (2vHPV) Revenue by Type (2020-2025)
4.2.2 Global 2-valent HPV Vaccine (2vHPV) Revenue by Type (2026-2031)
4.2.3 Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Type (2020-2031)
4.3 Global 2-valent HPV Vaccine (2vHPV) Price by Type (2020-2031)
5 Segment by Application
5.1 Global 2-valent HPV Vaccine (2vHPV) Sales by Application (2020-2031)
5.1.1 Global 2-valent HPV Vaccine (2vHPV) Sales by Application (2020-2025)
5.1.2 Global 2-valent HPV Vaccine (2vHPV) Sales by Application (2026-2031)
5.1.3 Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Application (2020-2031)
5.2 Global 2-valent HPV Vaccine (2vHPV) Revenue by Application (2020-2031)
5.2.1 Global 2-valent HPV Vaccine (2vHPV) Revenue by Application (2020-2025)
5.2.2 Global 2-valent HPV Vaccine (2vHPV) Revenue by Application (2026-2031)
5.2.3 Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Application (2020-2031)
5.3 Global 2-valent HPV Vaccine (2vHPV) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline Biologicals
6.1.1 GlaxoSmithKline Biologicals Company Information
6.1.2 GlaxoSmithKline Biologicals Description and Business Overview
6.1.3 GlaxoSmithKline Biologicals 2-valent HPV Vaccine (2vHPV) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Biologicals 2-valent HPV Vaccine (2vHPV) Product Portfolio
6.1.5 GlaxoSmithKline Biologicals Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck 2-valent HPV Vaccine (2vHPV) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck 2-valent HPV Vaccine (2vHPV) Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Beijing Wantai Biological Pharmacy Enterprise
6.3.1 Beijing Wantai Biological Pharmacy Enterprise Company Information
6.3.2 Beijing Wantai Biological Pharmacy Enterprise Description and Business Overview
6.3.3 Beijing Wantai Biological Pharmacy Enterprise 2-valent HPV Vaccine (2vHPV) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Beijing Wantai Biological Pharmacy Enterprise 2-valent HPV Vaccine (2vHPV) Product Portfolio
6.3.5 Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
6.4 Xiamen Innovax Biotech
6.4.1 Xiamen Innovax Biotech Company Information
6.4.2 Xiamen Innovax Biotech Description and Business Overview
6.4.3 Xiamen Innovax Biotech 2-valent HPV Vaccine (2vHPV) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Xiamen Innovax Biotech 2-valent HPV Vaccine (2vHPV) Product Portfolio
6.4.5 Xiamen Innovax Biotech Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Company Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India 2-valent HPV Vaccine (2vHPV) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Serum Institute of India 2-valent HPV Vaccine (2vHPV) Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Company Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology 2-valent HPV Vaccine (2vHPV) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Walvax Biotechnology 2-valent HPV Vaccine (2vHPV) Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 2-valent HPV Vaccine (2vHPV) Industry Chain Analysis
7.2 2-valent HPV Vaccine (2vHPV) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 2-valent HPV Vaccine (2vHPV) Production Mode & Process Analysis
7.4 2-valent HPV Vaccine (2vHPV) Sales and Marketing
7.4.1 2-valent HPV Vaccine (2vHPV) Sales Channels
7.4.2 2-valent HPV Vaccine (2vHPV) Distributors
7.5 2-valent HPV Vaccine (2vHPV) Customer Analysis
8 2-valent HPV Vaccine (2vHPV) Market Dynamics
8.1 2-valent HPV Vaccine (2vHPV) Industry Trends
8.2 2-valent HPV Vaccine (2vHPV) Market Drivers
8.3 2-valent HPV Vaccine (2vHPV) Market Challenges
8.4 2-valent HPV Vaccine (2vHPV) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global 2-valent HPV Vaccine (2vHPV) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global 2-valent HPV Vaccine (2vHPV) Market Value by Immunization Schedule, (US$ Million) & (2024 VS 2031)
Table 3. Global 2-valent HPV Vaccine (2vHPV) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 4. Global 2-valent HPV Vaccine (2vHPV) Market Competitive Situation by Manufacturers in 2024
Table 5. Global 2-valent HPV Vaccine (2vHPV) Sales (K Units) of Key Manufacturers (2020-2025)
Table 6. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global 2-valent HPV Vaccine (2vHPV) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 8. Global 2-valent HPV Vaccine (2vHPV) Revenue Share by Manufacturers (2020-2025)
Table 9. Global Market 2-valent HPV Vaccine (2vHPV) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 10. Global Key Players of 2-valent HPV Vaccine (2vHPV), Industry Ranking, 2022 VS 2023 VS 2024
Table 11. Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Manufacturing Sites & Headquarters
Table 12. Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Product Type & Application
Table 13. Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Date of Enter into This Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global 2-valent HPV Vaccine (2vHPV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 2-valent HPV Vaccine (2vHPV) as of 2024)
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global 2-valent HPV Vaccine (2vHPV) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global 2-valent HPV Vaccine (2vHPV) Sales by Region (2020-2025) & (K Units)
Table 19. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Region (2020-2025)
Table 20. Global 2-valent HPV Vaccine (2vHPV) Sales by Region (2026-2031) & (K Units)
Table 21. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Region (2026-2031)
Table 22. Global 2-valent HPV Vaccine (2vHPV) Revenue by Region (2020-2025) & (US$ Million)
Table 23. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Region (2020-2025)
Table 24. Global 2-valent HPV Vaccine (2vHPV) Revenue by Region (2026-2031) & (US$ Million)
Table 25. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Region (2026-2031)
Table 26. North America 2-valent HPV Vaccine (2vHPV) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 27. North America 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2025) & (K Units)
Table 28. North America 2-valent HPV Vaccine (2vHPV) Sales by Country (2026-2031) & (K Units)
Table 29. North America 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2025) & (US$ Million)
Table 30. North America 2-valent HPV Vaccine (2vHPV) Revenue by Country (2026-2031) & (US$ Million)
Table 31. Europe 2-valent HPV Vaccine (2vHPV) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 32. Europe 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2025) & (K Units)
Table 33. Europe 2-valent HPV Vaccine (2vHPV) Sales by Country (2026-2031) & (K Units)
Table 34. Europe 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2025) & (US$ Million)
Table 35. Europe 2-valent HPV Vaccine (2vHPV) Revenue by Country (2026-2031) & (US$ Million)
Table 36. Asia Pacific 2-valent HPV Vaccine (2vHPV) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 37. Asia Pacific 2-valent HPV Vaccine (2vHPV) Sales by Region (2020-2025) & (K Units)
Table 38. Asia Pacific 2-valent HPV Vaccine (2vHPV) Sales by Region (2026-2031) & (K Units)
Table 39. Asia Pacific 2-valent HPV Vaccine (2vHPV) Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia Pacific 2-valent HPV Vaccine (2vHPV) Revenue by Region (2026-2031) & (US$ Million)
Table 41. Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 42. Latin America 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2025) & (K Units)
Table 43. Latin America 2-valent HPV Vaccine (2vHPV) Sales by Country (2026-2031) & (K Units)
Table 44. Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2025) & (US$ Million)
Table 45. Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Country (2026-2031) & (US$ Million)
Table 46. Middle East and Africa 2-valent HPV Vaccine (2vHPV) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 47. Middle East and Africa 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2025) & (K Units)
Table 48. Middle East and Africa 2-valent HPV Vaccine (2vHPV) Sales by Country (2026-2031) & (K Units)
Table 49. Middle East and Africa 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2025) & (US$ Million)
Table 50. Middle East and Africa 2-valent HPV Vaccine (2vHPV) Revenue by Country (2026-2031) & (US$ Million)
Table 51. Global 2-valent HPV Vaccine (2vHPV) Sales (K Units) by Type (2020-2025)
Table 52. Global 2-valent HPV Vaccine (2vHPV) Sales (K Units) by Type (2026-2031)
Table 53. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Type (2020-2025)
Table 54. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Type (2026-2031)
Table 55. Global 2-valent HPV Vaccine (2vHPV) Revenue (US$ Million) by Type (2020-2025)
Table 56. Global 2-valent HPV Vaccine (2vHPV) Revenue (US$ Million) by Type (2026-2031)
Table 57. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Type (2020-2025)
Table 58. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Type (2026-2031)
Table 59. Global 2-valent HPV Vaccine (2vHPV) Price (US$/Unit) by Type (2020-2025)
Table 60. Global 2-valent HPV Vaccine (2vHPV) Price (US$/Unit) by Type (2026-2031)
Table 61. Global 2-valent HPV Vaccine (2vHPV) Sales (K Units) by Application (2020-2025)
Table 62. Global 2-valent HPV Vaccine (2vHPV) Sales (K Units) by Application (2026-2031)
Table 63. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Application (2020-2025)
Table 64. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Application (2026-2031)
Table 65. Global 2-valent HPV Vaccine (2vHPV) Revenue (US$ Million) by Application (2020-2025)
Table 66. Global 2-valent HPV Vaccine (2vHPV) Revenue (US$ Million) by Application (2026-2031)
Table 67. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Application (2020-2025)
Table 68. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Application (2026-2031)
Table 69. Global 2-valent HPV Vaccine (2vHPV) Price (US$/Unit) by Application (2020-2025)
Table 70. Global 2-valent HPV Vaccine (2vHPV) Price (US$/Unit) by Application (2026-2031)
Table 71. GlaxoSmithKline Biologicals Company Information
Table 72. GlaxoSmithKline Biologicals Description and Business Overview
Table 73. GlaxoSmithKline Biologicals 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 74. GlaxoSmithKline Biologicals 2-valent HPV Vaccine (2vHPV) Product
Table 75. GlaxoSmithKline Biologicals Recent Developments/Updates
Table 76. Merck Company Information
Table 77. Merck Description and Business Overview
Table 78. Merck 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 79. Merck 2-valent HPV Vaccine (2vHPV) Product
Table 80. Merck Recent Developments/Updates
Table 81. Beijing Wantai Biological Pharmacy Enterprise Company Information
Table 82. Beijing Wantai Biological Pharmacy Enterprise Description and Business Overview
Table 83. Beijing Wantai Biological Pharmacy Enterprise 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 84. Beijing Wantai Biological Pharmacy Enterprise 2-valent HPV Vaccine (2vHPV) Product
Table 85. Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
Table 86. Xiamen Innovax Biotech Company Information
Table 87. Xiamen Innovax Biotech Description and Business Overview
Table 88. Xiamen Innovax Biotech 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 89. Xiamen Innovax Biotech 2-valent HPV Vaccine (2vHPV) Product
Table 90. Xiamen Innovax Biotech Recent Developments/Updates
Table 91. Serum Institute of India Company Information
Table 92. Serum Institute of India Description and Business Overview
Table 93. Serum Institute of India 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 94. Serum Institute of India 2-valent HPV Vaccine (2vHPV) Product
Table 95. Serum Institute of India Recent Developments/Updates
Table 96. Walvax Biotechnology Company Information
Table 97. Walvax Biotechnology Description and Business Overview
Table 98. Walvax Biotechnology 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Walvax Biotechnology 2-valent HPV Vaccine (2vHPV) Product
Table 100. Walvax Biotechnology Recent Developments/Updates
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. 2-valent HPV Vaccine (2vHPV) Distributors List
Table 104. 2-valent HPV Vaccine (2vHPV) Customers List
Table 105. 2-valent HPV Vaccine (2vHPV) Market Trends
Table 106. 2-valent HPV Vaccine (2vHPV) Market Drivers
Table 107. 2-valent HPV Vaccine (2vHPV) Market Challenges
Table 108. 2-valent HPV Vaccine (2vHPV) Market Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
Table 112. Authors List of This Report
List of Figures
Figure 1. Product Picture of 2-valent HPV Vaccine (2vHPV)
Figure 2. Global 2-valent HPV Vaccine (2vHPV) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global 2-valent HPV Vaccine (2vHPV) Market Share by Type: 2024 & 2031
Figure 4. HPV16 Product Picture
Figure 5. HPV18 Product Picture
Figure 6. Global 2-valent HPV Vaccine (2vHPV) Market Value by Immunization Schedule, (US$ Million) & (2020-2031)
Figure 7. Global 2-valent HPV Vaccine (2vHPV) Market Share by Immunization Schedule: 2024 VS 2031
Figure 8. 2-Dose Regimen Product Picture
Figure 9. 3-Dose Regimen Product Picture
Figure 10. Global 2-valent HPV Vaccine (2vHPV) Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global 2-valent HPV Vaccine (2vHPV) Market Share by Application: 2024 & 2031
Figure 12. 9-16 Years Old
Figure 13. 16-20 Years Old
Figure 14. 20-26 Years Old
Figure 15. 26-45 Years Old
Figure 16. Global 2-valent HPV Vaccine (2vHPV) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global 2-valent HPV Vaccine (2vHPV) Market Size (2020-2031) & (US$ Million)
Figure 18. Global 2-valent HPV Vaccine (2vHPV) Sales (2020-2031) & (K Units)
Figure 19. Global 2-valent HPV Vaccine (2vHPV) Average Price (US$/Unit) & (2020-2031)
Figure 20. 2-valent HPV Vaccine (2vHPV) Report Years Considered
Figure 21. 2-valent HPV Vaccine (2vHPV) Sales Share by Manufacturers in 2024
Figure 22. Global 2-valent HPV Vaccine (2vHPV) Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest 2-valent HPV Vaccine (2vHPV) Players: Market Share by Revenue in 2-valent HPV Vaccine (2vHPV) in 2024
Figure 24. 2-valent HPV Vaccine (2vHPV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global 2-valent HPV Vaccine (2vHPV) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America 2-valent HPV Vaccine (2vHPV) Sales Market Share by Country (2020-2031)
Figure 27. North America 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Country (2020-2031)
Figure 28. United States 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe 2-valent HPV Vaccine (2vHPV) Sales Market Share by Country (2020-2031)
Figure 31. Europe 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Country (2020-2031)
Figure 32. Germany 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific 2-valent HPV Vaccine (2vHPV) Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Region (2020-2031)
Figure 39. China 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America 2-valent HPV Vaccine (2vHPV) Sales Market Share by Country (2020-2031)
Figure 49. Latin America 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Country (2020-2031)
Figure 50. Mexico 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa 2-valent HPV Vaccine (2vHPV) Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Country (2020-2031)
Figure 55. Turkey 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of 2-valent HPV Vaccine (2vHPV) by Type (2020-2031)
Figure 59. Global Revenue Market Share of 2-valent HPV Vaccine (2vHPV) by Type (2020-2031)
Figure 60. Global 2-valent HPV Vaccine (2vHPV) Price (US$/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of 2-valent HPV Vaccine (2vHPV) by Application (2020-2031)
Figure 62. Global Revenue Market Share of 2-valent HPV Vaccine (2vHPV) by Application (2020-2031)
Figure 63. Global 2-valent HPV Vaccine (2vHPV) Price (US$/Unit) by Application (2020-2031)
Figure 64. 2-valent HPV Vaccine (2vHPV) Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global 2-valent HPV Vaccine (2vHPV) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global 2-valent HPV Vaccine (2vHPV) Market Value by Immunization Schedule, (US$ Million) & (2024 VS 2031)
Table 3. Global 2-valent HPV Vaccine (2vHPV) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 4. Global 2-valent HPV Vaccine (2vHPV) Market Competitive Situation by Manufacturers in 2024
Table 5. Global 2-valent HPV Vaccine (2vHPV) Sales (K Units) of Key Manufacturers (2020-2025)
Table 6. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Manufacturers (2020-2025)
Table 7. Global 2-valent HPV Vaccine (2vHPV) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 8. Global 2-valent HPV Vaccine (2vHPV) Revenue Share by Manufacturers (2020-2025)
Table 9. Global Market 2-valent HPV Vaccine (2vHPV) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 10. Global Key Players of 2-valent HPV Vaccine (2vHPV), Industry Ranking, 2022 VS 2023 VS 2024
Table 11. Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Manufacturing Sites & Headquarters
Table 12. Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Product Type & Application
Table 13. Global Key Manufacturers of 2-valent HPV Vaccine (2vHPV), Date of Enter into This Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global 2-valent HPV Vaccine (2vHPV) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 2-valent HPV Vaccine (2vHPV) as of 2024)
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global 2-valent HPV Vaccine (2vHPV) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global 2-valent HPV Vaccine (2vHPV) Sales by Region (2020-2025) & (K Units)
Table 19. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Region (2020-2025)
Table 20. Global 2-valent HPV Vaccine (2vHPV) Sales by Region (2026-2031) & (K Units)
Table 21. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Region (2026-2031)
Table 22. Global 2-valent HPV Vaccine (2vHPV) Revenue by Region (2020-2025) & (US$ Million)
Table 23. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Region (2020-2025)
Table 24. Global 2-valent HPV Vaccine (2vHPV) Revenue by Region (2026-2031) & (US$ Million)
Table 25. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Region (2026-2031)
Table 26. North America 2-valent HPV Vaccine (2vHPV) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 27. North America 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2025) & (K Units)
Table 28. North America 2-valent HPV Vaccine (2vHPV) Sales by Country (2026-2031) & (K Units)
Table 29. North America 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2025) & (US$ Million)
Table 30. North America 2-valent HPV Vaccine (2vHPV) Revenue by Country (2026-2031) & (US$ Million)
Table 31. Europe 2-valent HPV Vaccine (2vHPV) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 32. Europe 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2025) & (K Units)
Table 33. Europe 2-valent HPV Vaccine (2vHPV) Sales by Country (2026-2031) & (K Units)
Table 34. Europe 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2025) & (US$ Million)
Table 35. Europe 2-valent HPV Vaccine (2vHPV) Revenue by Country (2026-2031) & (US$ Million)
Table 36. Asia Pacific 2-valent HPV Vaccine (2vHPV) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 37. Asia Pacific 2-valent HPV Vaccine (2vHPV) Sales by Region (2020-2025) & (K Units)
Table 38. Asia Pacific 2-valent HPV Vaccine (2vHPV) Sales by Region (2026-2031) & (K Units)
Table 39. Asia Pacific 2-valent HPV Vaccine (2vHPV) Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia Pacific 2-valent HPV Vaccine (2vHPV) Revenue by Region (2026-2031) & (US$ Million)
Table 41. Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 42. Latin America 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2025) & (K Units)
Table 43. Latin America 2-valent HPV Vaccine (2vHPV) Sales by Country (2026-2031) & (K Units)
Table 44. Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2025) & (US$ Million)
Table 45. Latin America 2-valent HPV Vaccine (2vHPV) Revenue by Country (2026-2031) & (US$ Million)
Table 46. Middle East and Africa 2-valent HPV Vaccine (2vHPV) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 47. Middle East and Africa 2-valent HPV Vaccine (2vHPV) Sales by Country (2020-2025) & (K Units)
Table 48. Middle East and Africa 2-valent HPV Vaccine (2vHPV) Sales by Country (2026-2031) & (K Units)
Table 49. Middle East and Africa 2-valent HPV Vaccine (2vHPV) Revenue by Country (2020-2025) & (US$ Million)
Table 50. Middle East and Africa 2-valent HPV Vaccine (2vHPV) Revenue by Country (2026-2031) & (US$ Million)
Table 51. Global 2-valent HPV Vaccine (2vHPV) Sales (K Units) by Type (2020-2025)
Table 52. Global 2-valent HPV Vaccine (2vHPV) Sales (K Units) by Type (2026-2031)
Table 53. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Type (2020-2025)
Table 54. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Type (2026-2031)
Table 55. Global 2-valent HPV Vaccine (2vHPV) Revenue (US$ Million) by Type (2020-2025)
Table 56. Global 2-valent HPV Vaccine (2vHPV) Revenue (US$ Million) by Type (2026-2031)
Table 57. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Type (2020-2025)
Table 58. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Type (2026-2031)
Table 59. Global 2-valent HPV Vaccine (2vHPV) Price (US$/Unit) by Type (2020-2025)
Table 60. Global 2-valent HPV Vaccine (2vHPV) Price (US$/Unit) by Type (2026-2031)
Table 61. Global 2-valent HPV Vaccine (2vHPV) Sales (K Units) by Application (2020-2025)
Table 62. Global 2-valent HPV Vaccine (2vHPV) Sales (K Units) by Application (2026-2031)
Table 63. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Application (2020-2025)
Table 64. Global 2-valent HPV Vaccine (2vHPV) Sales Market Share by Application (2026-2031)
Table 65. Global 2-valent HPV Vaccine (2vHPV) Revenue (US$ Million) by Application (2020-2025)
Table 66. Global 2-valent HPV Vaccine (2vHPV) Revenue (US$ Million) by Application (2026-2031)
Table 67. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Application (2020-2025)
Table 68. Global 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Application (2026-2031)
Table 69. Global 2-valent HPV Vaccine (2vHPV) Price (US$/Unit) by Application (2020-2025)
Table 70. Global 2-valent HPV Vaccine (2vHPV) Price (US$/Unit) by Application (2026-2031)
Table 71. GlaxoSmithKline Biologicals Company Information
Table 72. GlaxoSmithKline Biologicals Description and Business Overview
Table 73. GlaxoSmithKline Biologicals 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 74. GlaxoSmithKline Biologicals 2-valent HPV Vaccine (2vHPV) Product
Table 75. GlaxoSmithKline Biologicals Recent Developments/Updates
Table 76. Merck Company Information
Table 77. Merck Description and Business Overview
Table 78. Merck 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 79. Merck 2-valent HPV Vaccine (2vHPV) Product
Table 80. Merck Recent Developments/Updates
Table 81. Beijing Wantai Biological Pharmacy Enterprise Company Information
Table 82. Beijing Wantai Biological Pharmacy Enterprise Description and Business Overview
Table 83. Beijing Wantai Biological Pharmacy Enterprise 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 84. Beijing Wantai Biological Pharmacy Enterprise 2-valent HPV Vaccine (2vHPV) Product
Table 85. Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
Table 86. Xiamen Innovax Biotech Company Information
Table 87. Xiamen Innovax Biotech Description and Business Overview
Table 88. Xiamen Innovax Biotech 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 89. Xiamen Innovax Biotech 2-valent HPV Vaccine (2vHPV) Product
Table 90. Xiamen Innovax Biotech Recent Developments/Updates
Table 91. Serum Institute of India Company Information
Table 92. Serum Institute of India Description and Business Overview
Table 93. Serum Institute of India 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 94. Serum Institute of India 2-valent HPV Vaccine (2vHPV) Product
Table 95. Serum Institute of India Recent Developments/Updates
Table 96. Walvax Biotechnology Company Information
Table 97. Walvax Biotechnology Description and Business Overview
Table 98. Walvax Biotechnology 2-valent HPV Vaccine (2vHPV) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Walvax Biotechnology 2-valent HPV Vaccine (2vHPV) Product
Table 100. Walvax Biotechnology Recent Developments/Updates
Table 101. Key Raw Materials Lists
Table 102. Raw Materials Key Suppliers Lists
Table 103. 2-valent HPV Vaccine (2vHPV) Distributors List
Table 104. 2-valent HPV Vaccine (2vHPV) Customers List
Table 105. 2-valent HPV Vaccine (2vHPV) Market Trends
Table 106. 2-valent HPV Vaccine (2vHPV) Market Drivers
Table 107. 2-valent HPV Vaccine (2vHPV) Market Challenges
Table 108. 2-valent HPV Vaccine (2vHPV) Market Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
Table 112. Authors List of This Report
List of Figures
Figure 1. Product Picture of 2-valent HPV Vaccine (2vHPV)
Figure 2. Global 2-valent HPV Vaccine (2vHPV) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global 2-valent HPV Vaccine (2vHPV) Market Share by Type: 2024 & 2031
Figure 4. HPV16 Product Picture
Figure 5. HPV18 Product Picture
Figure 6. Global 2-valent HPV Vaccine (2vHPV) Market Value by Immunization Schedule, (US$ Million) & (2020-2031)
Figure 7. Global 2-valent HPV Vaccine (2vHPV) Market Share by Immunization Schedule: 2024 VS 2031
Figure 8. 2-Dose Regimen Product Picture
Figure 9. 3-Dose Regimen Product Picture
Figure 10. Global 2-valent HPV Vaccine (2vHPV) Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global 2-valent HPV Vaccine (2vHPV) Market Share by Application: 2024 & 2031
Figure 12. 9-16 Years Old
Figure 13. 16-20 Years Old
Figure 14. 20-26 Years Old
Figure 15. 26-45 Years Old
Figure 16. Global 2-valent HPV Vaccine (2vHPV) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global 2-valent HPV Vaccine (2vHPV) Market Size (2020-2031) & (US$ Million)
Figure 18. Global 2-valent HPV Vaccine (2vHPV) Sales (2020-2031) & (K Units)
Figure 19. Global 2-valent HPV Vaccine (2vHPV) Average Price (US$/Unit) & (2020-2031)
Figure 20. 2-valent HPV Vaccine (2vHPV) Report Years Considered
Figure 21. 2-valent HPV Vaccine (2vHPV) Sales Share by Manufacturers in 2024
Figure 22. Global 2-valent HPV Vaccine (2vHPV) Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest 2-valent HPV Vaccine (2vHPV) Players: Market Share by Revenue in 2-valent HPV Vaccine (2vHPV) in 2024
Figure 24. 2-valent HPV Vaccine (2vHPV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global 2-valent HPV Vaccine (2vHPV) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America 2-valent HPV Vaccine (2vHPV) Sales Market Share by Country (2020-2031)
Figure 27. North America 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Country (2020-2031)
Figure 28. United States 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe 2-valent HPV Vaccine (2vHPV) Sales Market Share by Country (2020-2031)
Figure 31. Europe 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Country (2020-2031)
Figure 32. Germany 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific 2-valent HPV Vaccine (2vHPV) Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Region (2020-2031)
Figure 39. China 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America 2-valent HPV Vaccine (2vHPV) Sales Market Share by Country (2020-2031)
Figure 49. Latin America 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Country (2020-2031)
Figure 50. Mexico 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa 2-valent HPV Vaccine (2vHPV) Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa 2-valent HPV Vaccine (2vHPV) Revenue Market Share by Country (2020-2031)
Figure 55. Turkey 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE 2-valent HPV Vaccine (2vHPV) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of 2-valent HPV Vaccine (2vHPV) by Type (2020-2031)
Figure 59. Global Revenue Market Share of 2-valent HPV Vaccine (2vHPV) by Type (2020-2031)
Figure 60. Global 2-valent HPV Vaccine (2vHPV) Price (US$/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of 2-valent HPV Vaccine (2vHPV) by Application (2020-2031)
Figure 62. Global Revenue Market Share of 2-valent HPV Vaccine (2vHPV) by Application (2020-2031)
Figure 63. Global 2-valent HPV Vaccine (2vHPV) Price (US$/Unit) by Application (2020-2031)
Figure 64. 2-valent HPV Vaccine (2vHPV) Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232